Mylan Curbs Medicines Co.'s Expert In Angiomax Patent Trial
An Illinois federal judge on Thursday partially granted a motion from Mylan Inc. to limit The Medicines Co.'s expert testimony in an upcoming patent trial over Mylan's planned generic version of...To view the full article, register now.
Already a subscriber? Click here to view full article